Second-trimester Down syndrome maternal serum screening in twin pregnancies: Impact of chorionicity

Prenatal Diagnosis

Volumn 23, Issue 4, 2003, Pages 331-335

  Muller, Françoise ^a   Dreux, Sophie ^a   Dupoizat, Henry ^b   Uzan, Serge ^c   Dubin, Marie Françoise ^d   Oury, Jean François ^e   Dingeon, Bernard ^f   Dommergues, Marc ^g  

^a HÔPITAL AMBROISE PARÉ   (France)

^b Laboratoire   (France)

^c HÔPITAL TENON   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f CENTRE HOSPITALIER DE CHAMBÉRY   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

AFP; Down syndrome; HCG; Multiple gestation; Prenatal screening; Trisomy 21; Twin pregnancies

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; DATA ANALYSIS; DOWN SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PRIORITY JOURNAL; RISK; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TWIN PREGNANCY;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; CHORION; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PREGNANCY, MULTIPLE; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; TWINS;

EID: 0037395306     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.594     Document Type: Article

References (15)

1. Alsat E, Wyplosz P, Malassine A, et al. 1996. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J Cell Physiol 168: 346-353.
2. Barnabei VM, Krantz DA, Macri JN, Larsen JW. 1995. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP. Prenat Diagn 15: 1131-1134.
3. Cuckle H. 1998. Down's syndrome screening in twins. J Med Screen 5: 3,4.
4. Fisk NM, Bennett PR. 1995. Prenatal determination of chorionicity and zygosity. In Multiple Pregnancy, Ward RH, White M (eds). RCOG press: London; 56-67.
5. Meyers C, Adam R, Dungan J, Prenger V. 1997. Aneuploidy in twin gestations: when is maternal age advanced? Obstet Gynaecol 89: 248-251.
6. Monni G, Zoppi MA, Ibba RM, Putzolu M, Floris M. 2000. Nuchal translucency in multiple pregnancies. Croat Med J 41: 266-269.
7. Muller F, Forestier F, Dingeon B, for ABA group. 2002. Results of second-trimester trisomy 21 maternal serum marker screening of 854 902 patients. Prenat Diagn 22: 925-929.
8. Neveux LM, Palomäki GE, Knight GJ, Haddow JE. 1996. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 16: 29-34.
9. Räty R, Virtanen A, Koskinen P, et al. 2000. Maternal midtrimester serum AFP and free β-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 20: 221-223.
10. Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH 1996. Screening for trisomy 21 in twin pregnancies by maternal age, fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 103: 999-1003.
11. Spencer K, Salonen R, Muller F. 1994. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein, free beta hCG. Prenat Diagn 14: 537-542.
12. Spencer K. 2000. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 20: 91-95.
13. Spencer K. 2001. Screening for trisomy 21 in twin pregnancies in first trimester: does chorionicity impact on maternal serum free β-hCG or PAPP-A levels? Prenat Diagn 21: 715-717.
14. Wald N, Cuckle H, Hu T, George L. 1991. Maternal serum unconjugated oestriol and human chorionic gonadotropin levels in twin pregnancies: implications for screening for Down syndrome. Br J Obstet Gynaecol 98: 905-908.
15. Wald NJ, Densem JW. 1994. Maternal serum free β-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn 14: 319,320.